天益医疗
(301097)
| 流通市值：7.43亿 | | | 总市值：23.89亿 |
| 流通股本：1834.74万 | | | 总股本：5894.74万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 565,402,506.87 | 192,155,136.94 | 380,403,459.47 | 612,886,168.96 |
| 应收票据及应收账款 | 54,610,572.22 | 54,859,400.45 | 45,641,634.06 | 41,801,738.33 |
| 其中：应收票据 | - | 773,042.5 | - | - |
| 应收账款 | 54,610,572.22 | 54,086,357.95 | 45,641,634.06 | 41,801,738.33 |
| 预付款项 | 12,876,715.54 | 8,537,880.14 | 20,503,934.59 | 19,495,007.16 |
| 其他应收款合计 | 5,385,342.08 | 5,684,636.14 | 7,777,210.38 | 7,743,320.25 |
| 存货 | 83,685,229.15 | 83,318,235.2 | 86,277,405.89 | 87,550,266.98 |
| 合同资产 | 33,749.55 | 33,749.55 | 20,176.99 | 20,176.99 |
| 其他流动资产 | 19,035,586.77 | 24,106,199.27 | 21,396,011.34 | 13,495,508.84 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,071,492,751.71 | 1,087,415,652.67 | 1,057,279,810.11 | 1,159,020,164.37 |
| 非流动资产: | | | | |
| 长期股权投资 | 26,866,199.95 | 27,937,794.32 | 28,926,104.63 | 29,933,246.32 |
| 其他非流动金融资产 | 24,000,000 | 24,000,000 | 23,336,493.17 | 23,580,227.56 |
| 投资性房地产 | 3,150,644.58 | 2,693,684.31 | 2,744,307.48 | 2,794,930.65 |
| 固定资产 | 282,314,965.1 | 286,323,975.51 | 280,229,568.03 | 281,341,064.15 |
| 在建工程 | 238,623,110.49 | 220,755,902.8 | 152,902,075.53 | 92,578,100.62 |
| 使用权资产 | 4,251,604.42 | 4,555,383.2 | 4,875,259.83 | 5,364,526.96 |
| 无形资产 | 75,193,798.56 | 75,705,879.54 | 76,220,403.12 | 76,640,560.38 |
| 长期待摊费用 | 12,528,846.69 | 12,541,334.06 | 7,313,598.33 | - |
| 递延所得税资产 | 2,898,167.97 | 2,564,529.59 | 2,315,226.21 | - |
| 其他非流动资产 | 27,621,902.02 | 26,931,215.15 | 74,624,867.12 | 68,109,781.87 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 697,449,239.78 | 684,009,698.48 | 653,487,903.45 | 580,342,438.51 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,768,941,991.49 | 1,771,425,351.15 | 1,710,767,713.56 | 1,739,362,602.88 |
| 流动负债: | | | | |
| 短期借款 | 139,086,472.22 | 188,607,586.11 | 227,884,925 | 238,262,343.06 |
| 交易性金融负债 | 1,606,676.03 | 8,553,647.04 | 3,005,613.23 | 1,598,744.98 |
| 应付票据及应付账款 | 70,555,498.16 | 75,917,892.04 | 54,053,353.89 | 64,105,982.84 |
| 应付账款 | 70,555,498.16 | 75,917,892.04 | 54,053,353.89 | 64,105,982.84 |
| 预收款项 | - | 53,623.85 | - | - |
| 合同负债 | 8,282,394.55 | 4,419,662.26 | 3,268,338.41 | 4,752,586.16 |
| 应付职工薪酬 | 15,298,194.61 | 23,043,925.64 | 17,340,958.74 | 13,294,295.46 |
| 应交税费 | 4,293,253.85 | 6,721,302.86 | 5,933,240.39 | 6,677,406.96 |
| 其他应付款合计 | - | 490,006.52 | 982,843.62 | 31,375,697.4 |
| 应付股利 | - | - | - | 29,473,684 |
| 一年内到期的非流动负债 | 30,250,408.61 | 736,056.75 | 1,144,079 | 1,299,504.6 |
| 其他流动负债 | 787,616.63 | 505,501.5 | 314,720.28 | 499,322.7 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 270,160,514.66 | 309,049,204.57 | 313,928,072.56 | 361,865,884.16 |
| 非流动负债: | | | | |
| 长期借款 | 208,439,293.06 | 168,546,791.93 | 108,900,000 | 108,900,000 |
| 租赁负债 | 3,802,505.94 | 3,913,246.71 | 4,113,931.18 | 4,215,201.25 |
| 递延收益 | 6,061,484.75 | 5,662,644.62 | 5,870,715.31 | 5,925,478.95 |
| 递延所得税负债 | - | - | - | 780,379.66 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 218,303,283.75 | 178,122,683.26 | 118,884,646.49 | 119,821,059.86 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 488,463,798.41 | 487,171,887.83 | 432,812,719.05 | 481,686,944.02 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 58,947,368 | 58,947,368 | 58,947,368 | 58,947,368 |
| 资本公积 | 793,393,386.97 | 793,393,386.97 | 788,787,166.69 | 788,787,166.69 |
| 减:库存股 | 7,386,481 | - | - | - |
| 其他综合收益 | -1,324,493.75 | -754,759.21 | 143,907.79 | 226,247.8 |
| 盈余公积 | 29,473,684 | 29,473,684 | 29,473,684 | 29,473,684 |
| 未分配利润 | 397,154,962.94 | 391,748,480.28 | 389,202,880.58 | 380,311,916.52 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,270,258,427.16 | 1,272,808,160.04 | 1,266,555,007.06 | 1,257,746,383.01 |
| 少数股东权益 | 10,219,765.92 | 11,445,303.28 | 11,399,987.45 | -70,724.15 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,280,478,193.08 | 1,284,253,463.32 | 1,277,954,994.51 | 1,257,675,658.86 |
| 负债和股东权益合计 | 1,768,941,991.49 | 1,771,425,351.15 | 1,710,767,713.56 | 1,739,362,602.88 |
| 公告日期 | 2024-04-25 | 2024-04-24 | 2023-10-25 | 2023-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |